4 results on '"Stanford, Miles"'
Search Results
2. Therapy for Ocular Toxoplasmosis - The Future.
- Author
-
Garweg, Justus G. and Stanford, Miles R.
- Subjects
- *
OCULAR toxoplasmosis , *VISUAL acuity , *PUBLIC health , *IMMUNOSUPPRESSION , *ANTIBIOTICS , *THERAPEUTICS ,DISEASE relapse prevention - Abstract
Background: Treatment of ocular toxoplasmosis is aimed at stabilizing visual function and reducing recurrence rates. Methods: Small controlled studies indicate that available treatments do not affect visual outcome and recurrence rates, and no antibiotic in current use will kill bradyzoites. Results: Antiparasitic treatment is justified in center-involving lesions and in large aggressive lesions namely in South American patients. Antibiotic treatment is needed for disease in the immunosuppressed, and this needs to be systemic. There exists strong agreement that a monotherapy, using steroids, is contraindicated. Prophylactic antibiotics may reduce recurrence rates in endemic areas and immunosuppressed patients. Conclusion: An ideal therapeutic strategy includes the strain of parasite, localization of the lesion, and severity of the inflammatory response as a basis for therapeutic decision making. New treatments targeting aspects of the parasite s physiology are very promising. On a global scale, public health measures to prevent transmission from animals and to access potable water are required. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
3. Therapy for Ocular Toxoplasmosis.
- Author
-
de-la-Torre, Alejandra, Stanford, Miles, Curi, Andre, Jaffe, Glenn J., and Gomez-Marin, Jorge E.
- Subjects
- *
OCULAR toxoplasmosis , *ANTI-infective agents , *CO-trimoxazole , *CLINDAMYCIN , *DEXAMETHASONE , *META-analysis , *CLINICAL trials , *THERAPEUTICS - Abstract
Purpose: To review current evidence for the treatment of ocular toxoplasmosis (OT). Design: Narrative review and expert recommendations. Methods: Meta-analysis and selected original articles from the medical literature were reviewed critically. Expert recommendations were analyzed. Results: Numerous observational studies suggest a benefit of short-term antimicrobial therapy for toxoplasmic retinochoroiditis in immunocompetent patients, although its efficacy has not been proven in randomized clinical trials. A randomized clinical trial revealed that intermittent trimethoprim/sulfamethoxazole treatment could decrease the rate of recurrence in high-risk patients. Intravitreal injection of clindamycin and dexamethasone was an acceptable alternative to the classic treatment for OT in a randomized clinical trial. Conclusions: Opinions about therapy differ and controversy remains about its type, efficacy, and length. Intravitreal therapy may be promising for OT. A recent description of the presence of parasitemia in patients with active and inactive ocular toxoplasmosis raises new questions that need to be explored. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
4. The Pathogenesis of Raised Intraocular Pressure in Uveitis.
- Author
-
Baneke, Alexander Jan, Lim, K. Sheng, and Stanford, Miles
- Subjects
- *
INTRAOCULAR pressure , *GLAUCOMA , *UVEITIS , *LITERATURE reviews , *OCULAR hypertension , *TRABECULAR meshwork (Eye) , *PATIENTS , *THERAPEUTICS , *DISEASE risk factors - Abstract
Aim: To analyze current understanding of the factors that contribute to raised intraocular pressure (IOP) in patients with uveitis. Methods: A pubmed literature review was carried out using words including “uveitic glaucoma”, “IOP AND uveitis”, “ocular hypertension AND uveitis”, “inflammation AND glaucoma”, “aqueous dynamics” AND “glaucoma/uveitis”. Results: Of the two studies looking at the aqueous dynamics in experimentally induced uveitis, both found aqueous flow decreased acutely, and one found that uveoscleral outflow increased. This is likely to reflect the types of uveitis that present acutely with hypotony. A study examining patients with Fuch’s heterochromic cyclitis found no difference in aqueous flow or uveoscleral outflow. No studies have examined aqueous dynamics in types of uveitis that present with acutely raised IOP. Levels of prostaglandins rise in acute uveitis, which has been shown to increase uveoscleral and trabecular outflow, without affecting aqueous flow. Studies have demonstrated that raised levels of trabecular protein reduce trabecular outflow. Steroid treatment, inflammatory cells, free radicals and enzymes are also likely to contribute to the development of raised pressure. When considering the impact of the pathogenesis of raised pressure in uveitis on its treatment, prostaglandins may provide good intraocular pressure control, but there are concerns regarding their theoretical ability to worsen the inflammatory response in uveitis. Studies have not conclusively proven this to be the case. Surgical success rates vary, but trabeculectomy plus an antimetabolite, deep sclerectomy plus an antimetabolite, and Ahmed valve surgery have been used. Conclusions: Uveitic glaucoma is caused by a number of different diseases, some of which present with acute hypotony, others with acutely raised IOP, and others which demonstrate an increase in IOP over time. Further studies should be carried out to examine the differing pathogenesis in these types of diseases, and to establish the best treatment options. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.